Top compounds associated with response to MT-ND4L


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC -0.055 0.1
mRNA LY-2183240 CTRPv2 pan-cancer AAC -0.054 0.1
mRNA erismodegib CTRPv2 pan-cancer AAC 0.064 0.1
mRNA tubastatin A CTRPv2 pan-cancer AAC -0.084 0.1
mRNA R428 CTRPv2 pan-cancer AAC -0.074 0.1
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.059 0.1
mRNA SN-38 CTRPv2 pan-cancer AAC -0.062 0.1
mRNA GSK2636771 CTRPv2 pan-cancer AAC -0.074 0.1
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.1
mRNA BRD-K16130065 CTRPv2 pan-cancer AAC 0.12 0.1
Download CSV